Low dose naltrexone might exert its effects on tumor growth through a mix of three Malignant Melanoma ; Multiple Myeloma; Neuroblastoma; Ovarian Cancer.
Low - dose Naltrexone or LDN is a new and experimental therapy for cancer. LDN is neuroblastoma, lymphocytic leukemia, lymphoma and melanoma. LDN.
Taking low doses of naltrexone has been shown to be able to enhance a neuroblastoma, prostate cancer, malignant melanoma, renal cell.
Researchers may have found a way to switch off auto-immune diseases